SHH and skin basal cell carcinoma: Moreover, even BCC cases without detectable genetic alterations in the SHH pathway show upregulation in Gli1 and Gli2, transcription factors downstream of the SHH pathway, indicating a potential dysregulation of other molecules that activate this signaling [12].